Fiduciary Group LLC Becton Dickinson & CO Transaction History

Fiduciary Group LLC

$971 Million
Q3 2024

A detailed history of Fiduciary Group LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Fiduciary Group LLC holds 24,864 shares of BDX stock, worth $5.57 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

24,864

Previous 25,690 3.22%

Holding current value

$5.57 Million

Previous $6 Million 0.17%

% of portfolio

0.62%

Previous 0.65%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$221.47 - $242.41 $182,934 - $200,230	-826 Reduced 3.22%	24,864 $5.99 Million
Q2 2024 Aug 08, 2024	SELL	$225.07 - $246.17 $102,631 - $112,253	-456 Reduced 1.74%	25,690 $6 Million
Q1 2024 May 13, 2024	BUY	$233.45 - $247.73 $51,125 - $54,252	219 Added 0.84%	26,146 $6.47 Million
Q4 2023 Feb 05, 2024	SELL	$232.24 - $267.23 $36,461 - $41,955	-157 Reduced 0.6%	25,927 $6.32 Million
Q3 2023 Nov 13, 2023	SELL	$254.9 - $283.59 $11,980 - $13,328	-47 Reduced 0.18%	26,084 $6.74 Million
Q2 2023 Jul 27, 2023	SELL	$238.39 - $265.32 $4,529 - $5,041	-19 Reduced 0.07%	26,131 $6.9 Million
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $69,142 - $78,064	-301 Reduced 1.14%	26,150 $6.47 Million
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $6,661 - $7,521	-29 Reduced 0.11%	26,121 $6.47 Million
Q4 2022 Feb 07, 2023	BUY	$218.29 - $256.91 $298,184 - $350,939	1,366 Added 5.45%	26,451 $6.73 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $187,790 - $972,366	3,680 Added 17.19%	25,085 $5.75 Million
Q2 2022 Aug 12, 2022	BUY	$234.74 - $275.42 $601,638 - $705,901	2,563 Added 13.6%	21,405 $5.28 Million
Q1 2022 May 13, 2022	BUY	$243.64 - $270.48 $1.74 Million - $1.93 Million	7,136 Added 60.96%	18,842 $4.69 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $70,174 - $76,536	-305 Reduced 2.54%	11,706 $2.94 Million
Q3 2021 Oct 27, 2021	SELL	$232.72 - $256.47 $50,965 - $56,166	-219 Reduced 1.79%	12,011 $2.96 Million
Q2 2021 Aug 05, 2021	BUY	$232.65 - $254.58 $27,220 - $29,785	117 Added 0.97%	12,230 $3.12 Million
Q1 2021 May 03, 2021	SELL	$232.09 - $256.88 $23,209 - $25,688	-100 Reduced 0.82%	12,113 $3.01 Million
Q4 2020 Feb 12, 2021	SELL	$221.92 - $245.94 $157,341 - $174,371	-709 Reduced 5.49%	12,213 $3.1 Million
Q3 2020 Nov 12, 2020	BUY	$215.77 - $276.76 $4,315 - $5,535	20 Added 0.16%	12,922 $3.01 Million
Q2 2020 Aug 14, 2020	SELL	$219.9 - $263.41 $65,970 - $79,023	-300 Reduced 2.27%	12,902 $3.09 Million
Q1 2020 May 11, 2020	SELL	$195.69 - $279.01 $27,396 - $39,061	-140 Reduced 1.05%	13,202 $3.03 Million
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $85,122 - $96,055	-360 Reduced 2.63%	13,342 $3.63 Million
Q3 2019 Nov 13, 2019	SELL	$230.58 - $256.08 $73,093 - $81,177	-317 Reduced 2.26%	13,702 $3.38 Million
Q2 2019 Aug 05, 2019	SELL	$217.4 - $246.08 $85,220 - $96,463	-392 Reduced 2.72%	14,019 $3.53 Million
Q1 2019 May 08, 2019	SELL	$206.05 - $248.17 $94,164 - $113,413	-457 Reduced 3.07%	14,411 $3.6 Million
Q4 2018 Feb 13, 2019	SELL	$204.73 - $257.93 $106,664 - $134,381	-521 Reduced 3.39%	14,868 $3.35 Million
Q3 2018 Oct 18, 2018	SELL	$233.07 - $256.0 $362,190 - $397,824	-1,554 Reduced 9.17%	15,389 $4.02 Million
Q2 2018 Aug 02, 2018	SELL	$208.1 - $233.85 $95,101 - $106,869	-457 Reduced 2.63%	16,943 $4.06 Million
Q1 2018 May 14, 2018	SELL	$205.46 - $240.27 $251,277 - $293,850	-1,223 Reduced 6.57%	17,400 $3.77 Million
Q4 2017 Feb 02, 2018	SELL	$189.0 - $222.64 $271,404 - $319,711	-1,436 Reduced 7.16%	18,623 $3.99 Million
Q3 2017 Nov 13, 2017	BUY	$186.89 - $198.9 $3.75 Million - $3.99 Million	20,059	20,059 $3.93 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.8B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Group LLC with notifications on news.

Account

Fiduciary Group LLC Becton Dickinson & CO Transaction History